Baystreet Staff -

Uni Care Home Health and Parallax Health Management Contract to Bring First-of-Its-Kind Good Health Outcomes Platform to Southern California

[ACCESSWIRE]

SANTA MONICA, CA / ACCESSWIRE / February 8, 2018 / Parallax Health Sciences, Inc. ("Parallax" or the "Company") (OTC PINK: PRLX) is an integrated digital healthcare company focused on connected health technology-enabled, integrated care delivery products and services, on a proprietary platform, that allows for remote communication, diagnosis, treatment, and monitoring of patients. Parallax's novel applications, patented interoperable point of care testing platforms, tests and devises, algorithm driven data analytic information systems, and patent-pending patient monitoring platform is designed for the evolving needs of today's healthcare system stakeholders; patients, payers, and providers. Parallax is pleased to announce today that its wholly-owned subsidiary, Parallax Health Management, Inc. ("PHM"), has contracted with Uni Care Home Health, Inc. ("Uni Care"), one of Southern California's largest Telehealth companies, to deploy "Good Health Outcomes," PHM's patent-pending Telehealth & Remote Patient Monitoring Platform to address the growing needs of Uni Care's patient population and increased insurance reimbursements related to their Remote Patient Care business.

Nathaniel Bradley, PHM's Chief Technology Officer, stated, "We are proud to be chosen by Uni Care to provide our Good Health Outcomes suite of services to Uni Care's 3,000+ home health patient population in San Diego, California and surrounding areas. With some 66% of patients not consistently taking their prescribed medicine, our proven technology is designed to increase patient compliance with their drug regimens while reducing costs."

Good Health Outcomes features a patent-pending Outcome Optimization Technology that has been precisely and specifically designed to increase patients' adherence to their medical regimens, resulting in healthier patients and a reduction in the costs associated with reduced patient adherence to their medical regimens.

"Parallax is on the cutting edge of Telehealth systems being delivered in the marketplace today," stated Paul Arena, Parallax's Chief Executive Officer. Mr. Arena further stated, "We are excited to be working with Uni Care in delivering state-of-the-art applications today. None of this is theoretical or waiting on the next big breakthrough. We are the breakthrough. Our patent pending patient monitoring platform combined with our data analytic information systems meets the needs of Uni Care and its rapidly growing patient population."

"We appreciate Parallax's approach that has focused on our needs for scalability and patient centric solutions at Uni Care," stated Albert Keshavrzi, Uni Care's Chief Executive Officer. Mr. Keshavrzi commented further saying, "By improving the quality of remote patient care solutions, we are able to provide from Uni Care, along with providing a greater quality of life for our patients coping with chronic disease management and acute rehabilitation. Parallax enables us to reduce our costs of care delivery while increasing the quality."

About Parallax Health Sciences, Inc.

Parallax Health Sciences, Inc. (PRLX), a Nevada corporation, is headquartered in Santa Monica, CA. The Company is focused on personalized patient healthcare through its wholly-owned subsidiaries, Parallax Health Management, Parallax Behavioral Health, and Parallax Diagnostics.

Please visit www.parallaxhealthsciences.com, www.parallaxhealthmanagement.com, www.parallaxdiagnostics.com, www.parallaxhealth.net, and www.roxsanpharmacy.com.

About Uni Care

Uni Care has been a long-time provider of home health and telehealth services within the San Diego and Riverside Counties. We are licensed by the State of California Department of Public Health, Medicare, and been recertified by The Joint Commission. We take pride in our wide range of professional clinical services and commendable customer service quality.

Catering to all our patients, including multi-lingual and multi-nationality patients, we prepare our staff for the bigger challenges of their work. We have clinicians and administrative staff who can speak English, Spanish, Farsi, Tagalog, Vietnamese, Hindi, and German to facilitate the delivery of services to our patients with their own language. By effectively delivering services to patients, we can help them to improve their health effectively and minimize unnecessary re-hospitalization. Please visit http://www.unicarehomehealth.com/.

Subject to the patient's eligibility and proper clinical authorization, we accept:

  • Medicare
  • Medicaid
  • Veterans Administration
  • Workers Compensation
  • HMOs & PPOs
  • Private Pay

Forward-Looking Statements

This release includes forward-looking statements contained within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding Parallax's expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions, are forward-looking statements. All forward-looking statements involve risks, uncertainties, and contingencies, many of which are beyond Parallax's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in Parallax's Form 10-K and other report filings with the SEC. Parallax is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, email investorrelations@parallaxhealthsciences.com.

SOURCE: Parallax Health Sciences, Inc.